Open original FDA record ↗Recall record
- FDA identifier
- Z-1899-2013
- Company in FDA record
- Nova Biomedical Corporation
- FDA classification date
- Aug 9, 2013
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 16, 2026
- Recall classification
- Class I
Reason stated in the source
Reports of false abnormally high glucose readings from test strips
Source facts
- Action
- Nova Biomedical U.S.A issued an Urgent Medical Device Voluntary Recall Letter dated July 19, 2013 via registered/certified letters to affected customers. The letter identified the affected product, problem and actions to be taken. Customers were instructed to immediately discontinue use of the affected product; contact Nova Diabetes Care Customer Service for replacement strips; do not stop testing blood glucose while waiting for replacement strips; if affected strips must be used follow precautions provided in notification letter. For questions call Nova Diabetes Care Customer Service at 1-800-681-7390. .
- Initiated
- 2013-07-15
- Root cause
- Material/Component Contamination
- Terminated
- 2017-08-01
- Distribution
- Worldwide Distribution - USA Nationwide and the countries of Chile, England , Peru, Nicaragua
- Recall number
- Z-1899-2013
- Recall status
- Terminated
- CDRH record ID
- 119720
- FDA classified
- 2013-08-09
- Recall event number
- 65617